Do intelligent electric toothbrushes replace professional tooth cleaning for gum inflammation?

Optimal Oral Care Regimen With or Without Professional Mechanical Plaque Removal in Managing Gingivitis (Gingival Inflammation): A Non-inferiority Randomized Controlled Trial

Not applicable Interventional Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · NCT07549347

We will test whether using an intelligent electric toothbrush with an oral-care routine can control gum inflammation in adults with gingivitis or early periodontitis as well as adding professional tooth cleaning.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment92 (estimated)
Ages18 Years to 64 Years
SexAll
SponsorShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
Trial IDNCT07549347 on ClinicalTrials.gov

What this trial studies

This is a randomized non-inferiority interventional trial comparing an optimal oral care regimen built around an intelligent electric toothbrush (i-Brush) and Oral‑B app to the same regimen plus professional mechanical plaque removal (PMPR) or a sham PMPR. Eligible adults (18–65 years) with gingivitis or stage I/localized stage II periodontitis and more than 20 teeth are randomized to receive the i‑Brush regimen alone or combined with PMPR, with clinicians measuring changes in gingival inflammation over the follow‑up period. The protocol includes oral hygiene instruction, standardized toothpaste use, and monitoring via the connected toothbrush/app to track adherence and brushing performance. Primary outcomes focus on gingival inflammation metrics to determine whether the i‑Brush regimen is non‑inferior to adding PMPR.

Who should consider this trial

Good fit: Adults aged 18–65 with gingivitis or stage I/localized stage II periodontitis who have more than 20 teeth and agree to use the i‑Brush with the Oral‑B app are ideal candidates.

Not a fit: People with advanced periodontitis, systemic diseases affecting periodontal outcomes, current pregnancy or lactation, recent antibiotics or professional periodontal treatment, or ongoing orthodontic treatment are unlikely to benefit from the results.

Why it matters

Potential benefit: If successful, this approach could reduce the need for routine professional cleanings, making effective gum care more accessible and lowering costs for large populations.

How similar studies have performed: Previous smaller studies have shown that intelligent toothbrush–based regimens can improve oral hygiene adherence and reduce plaque, but non‑inferiority versus PMPR has not been established.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. ≧18 years old and \< 65 years old
2. Gingivitis, Stage I and Localized Stage II Periodontitis
3. With more than 20 teeth
4. Agree to use the electronic I-brush with the Oral-B APP

Exclusion Criteria:

1. Presence of any systemic disease that can alter the outcome of periodontal treatment
2. Pregnancy or lactation during the study
3. Having received antibiotics within the previous 3 months
4. Having received professional periodontal treatment within the previous 3 months
5. With ongoing orthodontic treatment

Where this trial is running

Shanghai, Shanghai Municipality

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions GingivitisPeriodontitisartificial intelligenceinternet of things networkoral hygiene instructionprofessional mechanical plaque removalmobile health
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.